Skip to content

Is blood taken from intraosseous cannulation usable for laboratory assays in the acute setting?

Is blood taken from intraosseous cannulation usable for laboratory assays in the acute setting? - Laboratory assays on bonemarrow

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34033
Enrollment
20
Registered
2010-12-20
Start date
2011-05-16
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodynamisch instabiele patiënten op de SEH n.a.

Interventions

None listed

Sponsors

Atrium Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age: 18-80 years - Hemodynamic unstable patients in need of two vascular access routes.For example.: o Trauma o Shock o Cardiac arrest / resuscitation o Burnwounds. o Etc.

Exclusion criteria

Exclusion criteria: - Age: 80 year - Hemodynamic stable patients - Fracture of the proximale tibia - (Skin)infection of the proximale tibia

Design outcomes

Secondary

MeasureTime frame
Is the preanalytical quality of the bone marrow material sufficient for laboratory analysis. Quality will be assessed by using parameters such as hemolysss, lipaemia and the presence of bone fragments. The endpoint is the number of rejecte samples . Number and type of the complications that are related to the use of the intraosseous canulle in comparison to complications when using an intraveneous catheter.

Primary

MeasureTime frame
The main study parameter is the comparability of laboratory values (i.e. sodium, potassium, magnesium, calcium, glucose, lactate, albumin, creatinine, urea, alkalin phosphatase, γ-GT, LD, ALAT, ASAT, CK, TnT, CBC, PT and APTT) )in blood samples obtained by intraosseal cannulation and peripheral venous access.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)